Clinical finding | Group1-150 | No of positive cases/no of total cases | |||
---|---|---|---|---|---|
Initial episode | 4 months after | 6 years after | |||
Joint pain | B19 negative | 52/52 (100) | 4/52 (7.7)** | 2/52 (3.6)** | |
Joint pain | B19 positive | 12/12 (100) | 4/12 (33.3)** | 4/12 (33.3)** | |
Positive RF | B19 negative | 3/52 (5.8) | 3/52 (5.8)** | 3/52 (5.8)** | |
Positive RF | B19 positive | 1/12 (8.3) | 5/12 (41.6)** | 4/12 (33.3)** |
↵1-150 Each group was divided into two groups based on the evidence of 1gM anti-B19 antibody at beginning of the study. **p<0.01.